Cargando…

Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder

OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hursitoğlu, Onur, Kurutas, Ergül Belge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157002/
https://www.ncbi.nlm.nih.gov/pubmed/37119229
http://dx.doi.org/10.9758/cpn.2023.21.2.370
_version_ 1785036651996643328
author Hursitoğlu, Onur
Kurutas, Ergül Belge
author_facet Hursitoğlu, Onur
Kurutas, Ergül Belge
author_sort Hursitoğlu, Onur
collection PubMed
description OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. METHODS: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). RESULTS: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. CONCLUSION: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment.
format Online
Article
Text
id pubmed-10157002
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-101570022023-05-30 Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder Hursitoğlu, Onur Kurutas, Ergül Belge Clin Psychopharmacol Neurosci Original Article OBJECTIVE: Although there are neurobiological studies of patients with generalized anxiety disorder (GAD), the topic is still open to research. Lipid peroxidation can generate new molecular signal sequences by altering protein amounts and activity. 8-Iso-Prostaglandin F2aα (8-iso-PGF2α) is known to be an important lipid peroxidation marker. Raftlin, which is defined as a major lipid raft protein, is important for the regulation of signal transduction and inflammatory processes. METHODS: Our aim in this study was to compare the 8-iso-PGF2α and Raftlin levels of forty patients diagnosed with GAD and 40 healthy controls (age-sex and body mass index-matched). RESULTS: In the present study, increased serum 8-iso-PGF2α and Raftlin levels were found in patients with GAD compared to healthy controls. CONCLUSION: To our knowledge, this is the first study to examine 8-iso-PGF2α and Raftlin levels in patients with GAD. These results expand our knowledge of oxidative stress and inflammatory processes in patients with GAD. Our study should be considered preliminary and further studies should be performed with larger sample groups comparing values before and after treatment. Korean College of Neuropsychopharmacology 2023-05-30 2023-05-30 /pmc/articles/PMC10157002/ /pubmed/37119229 http://dx.doi.org/10.9758/cpn.2023.21.2.370 Text en Copyright© 2023, Korean College of Neuropsychopharmacology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hursitoğlu, Onur
Kurutas, Ergül Belge
Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title_full Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title_fullStr Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title_full_unstemmed Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title_short Serum Levels of 8-Iso-Prostaglandin F2aα and Raftlin in Patients with Generalized Anxiety Disorder
title_sort serum levels of 8-iso-prostaglandin f2aα and raftlin in patients with generalized anxiety disorder
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157002/
https://www.ncbi.nlm.nih.gov/pubmed/37119229
http://dx.doi.org/10.9758/cpn.2023.21.2.370
work_keys_str_mv AT hursitogluonur serumlevelsof8isoprostaglandinf2aaandraftlininpatientswithgeneralizedanxietydisorder
AT kurutasergulbelge serumlevelsof8isoprostaglandinf2aaandraftlininpatientswithgeneralizedanxietydisorder